MTHFR and prostate carcinoma: The MTHFR C677T variant has been associated with neural tube defects, cerebrovascular diseases [53, 54], coronary artery disease, venous thrombotic disease, and the rise in the risk of developing ovary cancer [55], esophagus cancer [56], gastric cancer [57], and prostate cancer [58].